Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell CancersBo Gao, Oliver Klein, Howard Chan et al.|JAMA Oncology|2025Cited by 18
Nivolumab and Ipilimumab in Advanced Mismatch Repair–Deficient/Microsatellite Instability–High Noncolorectal CancersMatteo S. Carlino, Oliver Klein, Bo Gao et al.|JAMA Oncology|2025Cited by 5
Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT TrialAdnan Nagrial, Oliver Klein, Matteo S. Carlino et al.|Clinical Cancer Research|2026Cited by 0
Data from Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT TrialAdnan Nagrial, Oliver Klein, Matteo S. Carlino et al.|Unknown|2026Cited by 0
Supplementary Table S1 from Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT TrialAdnan Nagrial, Oliver Klein, Matteo S. Carlino et al.|Unknown|2026Cited by 0